Omeros (OMER) Assets (2010 - 2026)
Omeros' (OMER) quarterly Assets came in at $286.2 million in Q1 2026, up 21.69% year-on-year from $235.2 million in Q1 2025, and down 12.12% quarter-over-quarter from $325.6 million in Q4 2025.
Omeros (OMER) Assets (2010 - 2026) Analysis & Trends
Omeros has disclosed Assets across 17 years of filings, most recently posting $286.2 million for Q1 2026.
- Assets for Q1 2026 came in at $286.2 million, up 21.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $286.2 million (up 21.69% YoY), and the FY2025 annual result was $325.6 million, up 17.52% from the prior year.
- Assets came in at $286.2 million for Q1 2026 at Omeros, down from $325.6 million in the prior quarter.
- In the past five years, Assets ranged from a high of $591.0 million in Q4 2022 to a low of $185.7 million in Q3 2025.
- The 5-year median for Assets is $356.3 million (2024), against an average of $372.9 million.
- Across the five-year window, Assets jumped 270.7% in 2022 and sank 46.25% in 2025, its largest moves.
- Omeros' Assets stood at $591.0 million in 2022, then slumped by 35.99% to $378.3 million in 2023, then dropped by 26.75% to $277.1 million in 2024, then advanced by 17.52% to $325.6 million in 2025, then retreated by 12.12% to $286.2 million in 2026.
- The last three Assets figures came in at $286.2 million (Q1 2026), $325.6 million (Q4 2025), and $185.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | 286.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 286.17 Mn |
| Dec 31, 2025 | 325.63 Mn |
| Sep 30, 2025 | 185.71 Mn |
| Jun 30, 2025 | 200.57 Mn |
| Mar 31, 2025 | 235.16 Mn |
| Dec 31, 2024 | 277.08 Mn |
| Sep 30, 2024 | 313.34 Mn |
| Jun 30, 2024 | 356.31 Mn |
| Mar 31, 2024 | 437.49 Mn |
| Dec 31, 2023 | 378.27 Mn |
| Sep 30, 2023 | 493.07 Mn |
| Jun 30, 2023 | 527.42 Mn |
| Mar 31, 2023 | 560.13 Mn |
| Dec 31, 2022 | 590.97 Mn |
| Sep 30, 2022 | 457.55 Mn |
| Jun 30, 2022 | 345.64 Mn |
| Mar 31, 2022 | 369.26 Mn |
| Dec 31, 2021 | 419.27 Mn |
| Sep 30, 2021 | 123.43 Mn |
| Jun 30, 2021 | 145.39 Mn |